Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Fischer

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
Pharmacoepidemiology and Drug Safety|July 17, 2004
Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefitMichael A Fischer, Jerry Avorn
Archives of Dermatology|April 18, 2007
Topical calcineurin inhibitors revisitedAbrar Qureshi, Michael A Fischer
The Virtual Mentor : VM|December 13, 2012
Educating Trainees about the Cost of MedicationsMichael A Fischer, Jerry Avorn
American Journal of Public Health|April 21, 2017
Restrictions of Hepatitis C Treatment for Substance-Using Medicaid Patients: Cost Versus EthicsJoshua M Liao, Michael A Fischer
Archives of Dermatology|May 17, 2006
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risksAbrar A Qureshi, Michael A Fischer
The New England Journal of Medicine|September 24, 2015
Early Patterns of Sofosbuvir Utilization by State Medicaid ProgramsJoshua M Liao, Michael A Fischer
Journal of General Internal Medicine|September 19, 2019
The Future of the Patient-Centered Outcomes Research Institute (PCORI)Michael A Fischer, Steven M Asch
JAMA Internal Medicine|August 15, 2018
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real WorldMichael Fralick, Elisabetta Patorno, Michael A Fischer
Health Affairs (Project Hope)|July 13, 2006
The rise and fall of Natrecor for congestive heart failure: implications for drug policyAaron S Kesselheim, Michael A Fischer, Jerry Avorn
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 6, 2020
Educating community clinicians using principles of academic detailing in an evolving landscapeAmanda G Kennedy, Loren Regier, Michael A Fischer
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
Pharmacoepidemiology and Drug Safety|July 17, 2004
Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefitMichael A Fischer, Jerry Avorn
Archives of Dermatology|April 18, 2007
Topical calcineurin inhibitors revisitedAbrar Qureshi, Michael A Fischer
The Virtual Mentor : VM|December 13, 2012
Educating Trainees about the Cost of MedicationsMichael A Fischer, Jerry Avorn
American Journal of Public Health|April 21, 2017
Restrictions of Hepatitis C Treatment for Substance-Using Medicaid Patients: Cost Versus EthicsJoshua M Liao, Michael A Fischer
Archives of Dermatology|May 17, 2006
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risksAbrar A Qureshi, Michael A Fischer
The New England Journal of Medicine|September 24, 2015
Early Patterns of Sofosbuvir Utilization by State Medicaid ProgramsJoshua M Liao, Michael A Fischer
Journal of General Internal Medicine|September 19, 2019
The Future of the Patient-Centered Outcomes Research Institute (PCORI)Michael A Fischer, Steven M Asch
JAMA Internal Medicine|August 15, 2018
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real WorldMichael Fralick, Elisabetta Patorno, Michael A Fischer
Health Affairs (Project Hope)|July 13, 2006
The rise and fall of Natrecor for congestive heart failure: implications for drug policyAaron S Kesselheim, Michael A Fischer, Jerry Avorn
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 6, 2020
Educating community clinicians using principles of academic detailing in an evolving landscapeAmanda G Kennedy, Loren Regier, Michael A Fischer
Pageof 22